Sinclair Pharma Plc (SPH) - Medical Equipment - Deals and Alliances Profile

Sinclair Pharma Plc (SPH) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME80664D
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimally-invasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclair's major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc (SPH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sinclair Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sinclair Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sinclair Pharma Plc, Medical Equipment, Deal Details 10

Asset Purchase 10

Sinclair Pharma to Acquire Worldwide Rights of Refine Support System from Refine for USD11.3 Million 10

Sinclair IS Pharma Acquires Atlean From Stiefel Labs 11

Private Equity 12

Huadong Medicine to Acquire Sinclair Pharma 12

Partnerships 14

Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 14

Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15

Equity Offering 16

Sinclair IS Pharma Announces Private Placement Of Shares For USD 33.4 Million 16

Sinclair IS Pharma Announces Private Placement Of Shares For USD 15 Million 17

Acquisition 18

Sinclair IS Pharma To Acquire Silhouette Medical For USD 117 Million 18

Sinclair IS Pharma Acquires AQTIS Medical 19

Sinclair Pharma Plc-Key Competitors 20

Sinclair Pharma Plc-Key Employees 21

Sinclair Pharma Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Financial Announcements 24

Sep 27, 2018: Sinclair Pharma: Interim results for the six months ended 30 June 2018 24

Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 28

Sep 19, 2017: Sinclair Pharma: Interim Results 31

Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 36

Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 37

Corporate Communications 38

Apr 30, 2018: Sinclair secures EUR23 million debt facility 38

Legal and Regulatory 39

Mar 30, 2017: Sinclair Pharma: Additional listing 39

Product News 40

Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil 40

Other Significant Developments 41

Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 41

Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Sinclair Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sinclair Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sinclair Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sinclair Pharma Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

Sinclair Pharma Plc, Medical Equipment, Key Facts, 2017 2

Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sinclair Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sinclair Pharma Plc, Deals By Market, 2012 to YTD 2018 8

Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sinclair Pharma to Acquire Worldwide Rights of Refine Support System from Refine for USD11.3 Million 10

Sinclair IS Pharma Acquires Atlean From Stiefel Labs 11

Huadong Medicine to Acquire Sinclair Pharma 12

Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 14

Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15

Sinclair IS Pharma Announces Private Placement Of Shares For USD 33.4 Million 16

Sinclair IS Pharma Announces Private Placement Of Shares For USD 15 Million 17

Sinclair IS Pharma To Acquire Silhouette Medical For USD 117 Million 18

Sinclair IS Pharma Acquires AQTIS Medical 19

Sinclair Pharma Plc, Key Competitors 20

Sinclair Pharma Plc, Key Employees 21

Sinclair Pharma Plc, Other Locations 22

Sinclair Pharma Plc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sinclair Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17980
Site License
USD 500 INR 35960
Corporate User License
USD 750 INR 53940

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com